Pharma News - Chemdiv

FDA generic drug approvals rose in 2023 in bid for improved access

The FDA's Office of Generic Drugs reported a rise in generic drug approvals, as several first-time generics entered the market.

Cyberattack At UnitedHealth's Change Healthcare Hits US Pharmacies

American Hospital Association or AHA urged healthcare facilities across the United States to disconnect from Change Healthcare.

US study identifies over 275 million new genetic variants from NIH research programme

Researchers from the US have discovered more than 275 million genetic variants identified through the National Institutes of Health’s (NIH) All of Us Research Program. ...

PepGen earns FDA Fast Track Designation for myotonic dystrophy type 1 candidate

A Phase I trial studying the therapy is underway after an FDA clinical hold was lifted last year, with initial data expected in 2024.

Pfizer’s Velsipity granted EC approval for ulcerative colitis in patients aged from 16 years

The immune-mediated inflammatory bowel disease affects approximately 2.6 million people in Europe.

GSK Says HIV Shot Is Better than Daily Pills for Some Patients

All patients in a trial have been offered the long-acting drug. Drugmaker is betting on injectable treatments for HIV.

New model identifies drugs that shouldn’t be taken together

Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.

Study reveals T cells could provide more protection against Omicron in future vaccines

Researchers from Imperial College London (ICL) have revealed that T cells could provide more protection in COVID-19 vaccines against Omicron, a SARS-CoV-2 virus strain, than antibodies do. ...

WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma

PHILADELPHIA -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S.

Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees.

Recipients’ research focused on melanoma diagnosis, treatment response in advanced NSCLC, and bypassing common hurdles in NSCLC diagnosis and treatment

FDA warns vs fake versions of popular medicines

MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported. ...

Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...